PHARMAKEION LIMITED

Company number 09270317 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£400k -£300k -£200k -£100k £0 £100k £200k £300k £400k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £357,900 Total assets 2017: £320,428 Total assets 2018: £287,734 Total assets 2019: £271,925 Total assets 2020: £266,318 Total assets 2021: £257,499 Total assets 2022: £303,179 Total assets 2023: £242,455 Total assets 2024: £207,929 Total assets 2025: £209,098 Total assets Net assets 2016: -£32,699 Net assets 2017: £47,156 Net assets 2018: £46,509 Net assets 2019: £62,218 Net assets 2020: £65,674 Net assets 2021: £45,896 Net assets 2022: £2,200 Net assets 2023: £24,688 Net assets 2024: -£52,147 Net assets 2025: -£74,827 Net assets Total liabilities 2016: -£391,019 Total liabilities 2017: -£213,313 Total liabilities 2018: -£202,388 Total liabilities 2019: -£218,209 Total liabilities 2020: -£233,931 Total liabilities 2021: -£223,766 Total liabilities 2022: -£240,628 Total liabilities 2023: -£226,440 Total liabilities 2024: -£237,682 Total liabilities 2025: -£281,915 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 1 2 3 4 5 6 7 8 2024 2025 2024: 8 2025: 6

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2025-06-30): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-06-30 £209,098 -£281,915 -£74,827 6
2024-06-30 £207,929 -£237,682 -£52,147 8
2023-06-30 £242,455 -£226,440 £24,688
2022-06-30 £303,179 -£240,628 £2,200
2021-06-30 £257,499 -£223,766 £45,896
2020-06-30 £266,318 -£233,931 £65,674
2019-06-30 £271,925 -£218,209 £62,218
2018-06-30 £287,734 -£202,388 £46,509
2017-06-30 £320,428 -£213,313 £47,156
2016-06-30 £357,900 -£391,019 -£32,699
2015-06-30 £100 £0 £100 £100

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.